Genetic alterations associated with uterine leiomyoma are heterogeneous and they include mutations of mediator complex subunit 12 (MED12), overexpression of high mobility group AT-hook 2 (HMGA2), and inactivation of the fumarate hydratase (FH) gene [2]. The gene discussed is HMGA2; the disease is Uterine leiomyoma.